These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3881851)

  • 1. Cyclosporine plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection.
    Klintmalm G; Säwe J; Ringdén O; von Bahr C; Magnusson A
    Transplantation; 1985 Feb; 39(2):132-7. PubMed ID: 3881851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal cyclosporine plasma levels decline with time of therapy.
    Klintmalm G; Säwe J; von Bahr C; Ringdén O; Lundgren G; Wilczek H; Tydén G; Groth CG
    Transplant Proc; 1984 Oct; 16(5):1208-11. PubMed ID: 6385380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.
    Lindholm A; Dahlqvist R; Groth GG; Sjöqvist F
    Br J Clin Pharmacol; 1990 Sep; 30(3):443-52. PubMed ID: 2223423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective long-term immunosuppression maintained by low cyclosporine levels in primary cadaveric renal transplant recipients.
    Kupin WL; Venkat KK; Norris C; Florence-Green D; Dienst S; Oh HK; Feldkamp C; Levin NW
    Transplantation; 1987 Feb; 43(2):214-8. PubMed ID: 3544378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of steady-state cyclosporine concentrations on renal allograft outcome.
    Dunn J; Grevel J; Napoli K; Lewis RM; Van Buren CT; Kahan BD
    Transplantation; 1990 Jan; 49(1):30-4. PubMed ID: 2301023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose cyclosporine for cadaveric renal transplantation.
    Vanderwerf BA; Serota AI
    Transplantation; 1988 Feb; 45(2):320-3. PubMed ID: 3278422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation.
    Min DI; Perry PJ; Chen HY; Hunsicker LG
    Pharmacotherapy; 1998; 18(2):282-7. PubMed ID: 9545147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?
    Ubhi CS; Woodhouse L; Guillou PJ; Giles GR
    Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antilymphoblast globulin, cyclosporine, and steroids in cadaveric renal transplantation.
    Griño JM; Alsina J; Sabater R; Castelao AM; Gil-Vernet S; Andres E; Sabate I; Mestre M; Seron D; Diaz C
    Transplantation; 1990 Jun; 49(6):1114-7. PubMed ID: 2360253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of renal allograft dysfunction upon cyclosporine trough levels in host blood.
    Arnold AN; Waltzer WC; Anaise D; Weinstein SW; Rapaport FT
    Transplantation; 1985 Dec; 40(6):605-10. PubMed ID: 3907030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of whole blood cyclosporine measurements in renal transplantation using triple therapy.
    Nankivell BJ; Hibbins M; Chapman JR
    Transplantation; 1994 Nov; 58(9):989-96. PubMed ID: 7974738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
    Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcome of renal transplantation with cyclosporine compared with azathioprine--experience in 33 recipients followed for over one year.
    Yasumura T; Ohmori Y; Aikawa I; Fukuda M; Suzuki S; Nakai I; Matsui S; Oka T
    Jpn J Surg; 1986 May; 16(3):181-8. PubMed ID: 3525928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete replacement of methylprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Oh HK; Dienst S
    Transplantation; 1988 Jan; 45(1):53-5. PubMed ID: 3276062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine plasma levels six hours after oral administration. A useful tool for monitoring therapy.
    Cantarovich F; Bizollon C; Cantarovich D; Lefrançois N; Dubernard JM; Traeger J
    Transplantation; 1988 Feb; 45(2):389-94. PubMed ID: 3278433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.
    Waiser J; Slowinski T; Brinker-Paschke A; Budde K; Schreiber M; Böhler T; Hauser I; Neumayer HH
    Nephrol Dial Transplant; 2002 Jul; 17(7):1310-7. PubMed ID: 12105257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood levels of cyclosporine, acute rejections and the prognosis of the allografts in pediatric renal allograft recipients].
    Sakuma T; Ogawa O; Kawamura T; Hasegawa A; Kamidono S
    Nihon Hinyokika Gakkai Zasshi; 1995 Sep; 86(9):1450-9. PubMed ID: 7474634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition, diagnosis, and management of rejection in the second to sixth months posttransplant--an overview.
    Matas AJ; Tellis VA; Quinn T; Soberman R; Veith FJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):141-50. PubMed ID: 3515682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.